Introduction
Pioneering entrepreneur, investor, and former Genzyme executive Jim Geraghty, JD, MS, shares his extensive and ground-breaking experiences building and fostering biotech companies large and small—and how they overcame the many hurdles faced in developing treatments for rare and serious diseases. Geraghty also talks about his new book, Inside the Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology (Cold Spring Laboratory Press), which Nature called “[An] informative, sometimes passionate account [that] mixes patients' struggles with business, medicine, politics and technology."
